Company Overview of BEAT BioTherapeutics Corp.
BEAT BioTherapeutics Corp., a biotechnology company, develops therapies for the treatment of heart diseases. The company focuses on developing a gene therapy to improve cardiac performance in the setting of heart failure. Its gene therapy represents a transformational technology for the treatment of heart failure and myocardial infarctions. The company was founded in 2008 and is based in Bellevue, Washington.
1380-112th Avenue NE
Bellevue, WA 98004
Founded in 2008
Key Executives for BEAT BioTherapeutics Corp.
BEAT BioTherapeutics Corp. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact BEAT BioTherapeutics Corp., please visit www.beatbiotherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.